Biomarkers for deliriuma - A review

Babar A. Khan, Mohammed Zawahiri, Noll L. Campbell, Malaz A. Boustani

Research output: Contribution to journalReview article

53 Citations (Scopus)

Abstract

To improve delirium recognition and care, numerous serum biomarkers have been investigated as potential tools for risk stratification, diagnosis, monitoring, and prognostication of delirium. The literature was reviewed, and no evidence was found to support the clinical use of any delirium biomarker, although certain biomarkers such as S-100 beta and insulin-like growth factor-1 and inflammatory markers have shown some promising results that need to be evaluated in future studies with appropriate sample size, prospective designs, and in a more-generalizable population.

Original languageEnglish (US)
Pages (from-to)S256-S261
JournalJournal of the American Geriatrics Society
Volume59
Issue numberSUPPL. 2
DOIs
StatePublished - Nov 1 2011

Fingerprint

Delirium
Biomarkers
Somatomedins
Sample Size
Serum
Population

Keywords

  • biomarkers
  • delirium
  • serum

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

Biomarkers for deliriuma - A review. / Khan, Babar A.; Zawahiri, Mohammed; Campbell, Noll L.; Boustani, Malaz A.

In: Journal of the American Geriatrics Society, Vol. 59, No. SUPPL. 2, 01.11.2011, p. S256-S261.

Research output: Contribution to journalReview article

Khan, Babar A. ; Zawahiri, Mohammed ; Campbell, Noll L. ; Boustani, Malaz A. / Biomarkers for deliriuma - A review. In: Journal of the American Geriatrics Society. 2011 ; Vol. 59, No. SUPPL. 2. pp. S256-S261.
@article{65efa144324744478701e65efa0f16d7,
title = "Biomarkers for deliriuma - A review",
abstract = "To improve delirium recognition and care, numerous serum biomarkers have been investigated as potential tools for risk stratification, diagnosis, monitoring, and prognostication of delirium. The literature was reviewed, and no evidence was found to support the clinical use of any delirium biomarker, although certain biomarkers such as S-100 beta and insulin-like growth factor-1 and inflammatory markers have shown some promising results that need to be evaluated in future studies with appropriate sample size, prospective designs, and in a more-generalizable population.",
keywords = "biomarkers, delirium, serum",
author = "Khan, {Babar A.} and Mohammed Zawahiri and Campbell, {Noll L.} and Boustani, {Malaz A.}",
year = "2011",
month = "11",
day = "1",
doi = "10.1111/j.1532-5415.2011.03702.x",
language = "English (US)",
volume = "59",
pages = "S256--S261",
journal = "Journal of the American Geriatrics Society",
issn = "0002-8614",
publisher = "Wiley-Blackwell",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Biomarkers for deliriuma - A review

AU - Khan, Babar A.

AU - Zawahiri, Mohammed

AU - Campbell, Noll L.

AU - Boustani, Malaz A.

PY - 2011/11/1

Y1 - 2011/11/1

N2 - To improve delirium recognition and care, numerous serum biomarkers have been investigated as potential tools for risk stratification, diagnosis, monitoring, and prognostication of delirium. The literature was reviewed, and no evidence was found to support the clinical use of any delirium biomarker, although certain biomarkers such as S-100 beta and insulin-like growth factor-1 and inflammatory markers have shown some promising results that need to be evaluated in future studies with appropriate sample size, prospective designs, and in a more-generalizable population.

AB - To improve delirium recognition and care, numerous serum biomarkers have been investigated as potential tools for risk stratification, diagnosis, monitoring, and prognostication of delirium. The literature was reviewed, and no evidence was found to support the clinical use of any delirium biomarker, although certain biomarkers such as S-100 beta and insulin-like growth factor-1 and inflammatory markers have shown some promising results that need to be evaluated in future studies with appropriate sample size, prospective designs, and in a more-generalizable population.

KW - biomarkers

KW - delirium

KW - serum

UR - http://www.scopus.com/inward/record.url?scp=81555220082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81555220082&partnerID=8YFLogxK

U2 - 10.1111/j.1532-5415.2011.03702.x

DO - 10.1111/j.1532-5415.2011.03702.x

M3 - Review article

C2 - 22091570

AN - SCOPUS:81555220082

VL - 59

SP - S256-S261

JO - Journal of the American Geriatrics Society

JF - Journal of the American Geriatrics Society

SN - 0002-8614

IS - SUPPL. 2

ER -